Fouad Attieh

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Systematic Review

Papillary Thyroid

Tyrosine Kinase

Top Venues

Future oncology (London, England)

Medical oncology (Northwood, London, England)

Cancer investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Fouad Attieh, Marc Boutros, Hampig Raphaël Kourie, Mervat Mahrous
Turning the tide: pembrolizumab's triumph in adjuvant RCC therapy. Medical oncology (Northwood, London, England) 41 (10) (2024)
John-Victor El Khoury, Sophie Wehbe, Fouad Attieh, Marc Boutros, Carole Kesrouani, Hampig Raphaël Kourie
A critical review of RAF inhibitors in BRAF-mutated glioma treatment. Pharmacogenomics (2024)
Fouad Attieh, Hampig Raphaël Kourie
Breaking barriers: the latest insights into KRAS G12C inhibitors. Future oncology (London, England) (2024)
Antoine Mouawad, Sofia Habib, Marc Boutros, Fouad Attieh, Hampig Raphaël Kourie
How to find a needle in a haystack: a systematic review on targeting KRAS wild-type pancreatic cancer. Future oncology (London, England) (2024)
Antoine Chartouni, Antoine Mouawad, Marc Boutros, Fouad Attieh, Nicolas Medawar, Hampig Raphaël Kourie
Mesenchymal stem cells: a trojan horse to treat glioblastoma. Investigational new drugs (2023)
Fouad Attieh, Antoine Chartouni, Marc Boutros, Antoine Mouawad, Hampig Raphaël Kourie
Tackling the immunotherapy conundrum: advances and challenges for operable non-small-cell lung cancer treatment. Immunotherapy (2023)
Marc Boutros, Fouad Attieh, Antoine Chartouni, Johnny Jalbout, Hampig Raphaël Kourie
Beyond the Horizon: A Cutting-Edge Review of the Latest Checkpoint Inhibitors in Cancer Treatment for 2022. Cancer investigation (2023)